대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)

  • 제28권3호
  • /
  • Pages.74-84
  • /
  • 2014
  • /
  • 1226-8038(pISSN)
  • /
  • 2287-9463(eISSN)
대한한방소아과학회 (The Association of Korean Oriental Pediatrics)
권호 표지
DOI QR코드

DOI QR Code

Sensitiv ImagoTM, 양도락을 이용한 Duchenne Muscular Dystrophy 환아 1례의 검사 결과 보고

A Case Report : The Measurement Results of Duchenne Muscular Dystrophy Patient Using Sensitiv ImagoTM and Ryodoraku

  • 한주희 (경희대학교 한의과대학 임상한의학과 소아과학교실) ;
  • 김덕곤 (경희대학교 한의과대학 임상한의학과 소아과학교실) ;
  • 이진용 (경희대학교 한의과대학 임상한의학과 소아과학교실)
  • Han, Ju Hui (Pediatrics of Clinical Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Deog Gon (Pediatrics of Clinical Korean Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Lee, Jin Yong (Pediatrics of Clinical Korean Medicine, College of Korean Medicine, Kyung Hee University)
  • 투고 : 2014.07.25
  • 심사 : 2014.08.08
  • 발행 : 2014.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives The purpose of this study is to report the measurement results of Duchenne Muscular Dystrophy (DMD) in Patient Using Sensitiv $Imago^{TM}$ (SI) and Ryodoraku. Methods We conducted SI test and Ryodoraku test to a 7-year-old DMD patient who visited to Oriental pediatrics, Kyung Hee Medical Center. Results We obtained SI and Ryodoraku test results from a DMD patient. Conclusions Further study with more samples is necessary to establish accuracy of SI in clinical use.

키워드

참고문헌

  1. Bushby KM, Thambyayah M, Gardner-Medwin D. Prevalence and incidence of becker muscular dystrophy. Lancet. 1991;337:1022-4. https://doi.org/10.1016/0140-6736(91)92671-N
  2. Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton S, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther. 2011;19:830-40. https://doi.org/10.1038/mt.2011.59
  3. McNally EM. Duchenne muscular dystrophy: how bad is the heart?. Heart. 2008;94:976-7. https://doi.org/10.1136/hrt.2007.138461
  4. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord. 2003;13:166-72. https://doi.org/10.1016/S0960-8966(02)00213-4
  5. Chae JH. Neuromuscular disorders in children: diagnosis and treatment. Korean J Pediatr. 2008;51(12):1295-9. https://doi.org/10.3345/kjp.2008.51.12.1295
  6. Nakatani Y. Sign electric resistance and ryodoraku. J Auton Nerve. 1956;6:52.
  7. Park YB. The principle of ryodoraku and clinical utilization. The Third Medicine. 1996;1(2):83-94.
  8. Voll R. Twenty years of electricacupuncture diagnosis in germany: a progresive report. AM J Acupuncture. 1975;3:7-17.
  9. Sensitiv Imago. Sensitiv Imago Technology Official EU Office. Praque. 2014. available from http://sensitivimago.com(accessed May 2014).
  10. Yoo CK, Lee JS, Kwon GR. The clinical observation on one case of patient with progressive muscular dystrophies. J Korean Institute Herbal-Acupuncture. 2000;30(2):233-44. https://doi.org/10.3831/KPI.2000.3.2.233
  11. Lee JS, An CS, Kwon GR. A clinical study on the case of fascioscapulohumeral (FSH) muscular dystrophy treated with traditional korean medicine. J Korean Acupunct Moxibustion Soc. 2001;18(3):227-38.
  12. Jeon SW, Kim KS, Lee WG, Kim BH, Nam HJ, Kim YB. The study on the characteristics of ryodoraku parameters in the patients with acute and chronic urticaria. J Korean Orient Med Ophthalmol Otolaryngol Dermatol. 2011;24(2):35-40.
  13. Emery AE. The muscular dystrophies. Lancet. 2002;359:687-95. https://doi.org/10.1016/S0140-6736(02)07815-7
  14. Rudolph AM. Rudolph's Pediatrics, 19th ed. Connecticut; Appleton & Lange. 1991;1803-4.
  15. Morse RP, Rosman NP. Diagnosis of occult muscular dystrophy: Importance of the “chance” finding of elevated serum aminotransferase activities. J Pediatr. 1993;122:254-6. https://doi.org/10.1016/S0022-3476(06)80126-5
  16. Kim JK, Chung KS, Kim TS. Clinical and histologic study of progressive muscular dystrophy which was considered as chronic hepatitis. Korean J Pediatr. 1995;38(2):216-22.
  17. Sensitiv Imago. Alpha-Med Ukraine presents. Ukraine, Kiev; 2013. available from: http://www.aur-um.com.ua/eng/metod.htm(accessed May 2014).
  18. Hong WS. JUNG GYO HWANG JAE NAE KYUNG SO MOON. Seoul; Institute of Oriental Medicine Press. 1981:166-7.
  19. Kim RW. Analysis and application for components of CHUNG GAN GUN BI TANG. DONG YANG EUI HAK. 1979;9:16.
  20. Lee DH, Lee JY. The study on the characteristics of ryodoraku score in the children who visited department of pediatrics hospital of oriental medicine for growth treatment. J Pediatr Korean Med. 2007;21(3):145-56.
  21. Kim HK, Yoon SH, Ryu JM, Jang SY, Lee JS, Eom GH, Lee SY, Kim JS, Ryu BH, Ryu KW. Association of skin sympathetic tone or cardiovascular reactivity on the fatigue index in patients with functional dyspepsia. Korean J Orient Int Med. 2005;26(2):390-7.
  22. Cha JH, Kim YB, Shin YJ, Kim JM. A clinical study on the repeatability and reproducibility of ryodoraku score. J Korean Orient Med. 2009;30(1):76-82.
  23. Islamov BI, Balabanova RM, Funtikov VA, Gotovskii YV, Meizerov EE. Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med. 2002;134(3):248-50. https://doi.org/10.1023/A:1021599216581
  24. Ernst E. Bioresonance, a study of pseudo-scientific language. Forsch Komplementarmed Klass Naturheilkd.2004;11(3):171-3. https://doi.org/10.1159/000079446

피인용 문헌

  1. in Pediatric Patients vol.28, pp.4, 2014, https://doi.org/10.7778/jpkm.2014.28.4.0138